|
NMD3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.2692999999907E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.797500E-04 |
| Normal-vs-Stage2 |
2.55569999996208E-06 |
| Normal-vs-Stage3 |
2.238300E-04 |
| Normal-vs-Stage4 |
3.634600E-04 |
| Stage1-vs-Stage2 |
6.894100E-02 |
| Stage1-vs-Stage3 |
5.873200E-01 |
| Stage1-vs-Stage4 |
4.909200E-01 |
| Stage2-vs-Stage3 |
1.849450E-01 |
| Stage2-vs-Stage4 |
3.120800E-01 |
| Stage3-vs-Stage4 |
8.004000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.157660E-04 |
| Normal-vs-AfricanAmerican |
8.308300E-02 |
| Normal-vs-Asian |
4.372000E-04 |
| Caucasian-vs-AfricanAmerican |
3.584800E-01 |
| Caucasian-vs-Asian |
5.363400E-01 |
| AfricanAmerican-vs-Asian |
2.076800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.248699999996E-05 |
| Normal-vs-Female |
8.22650000000813E-05 |
| Male-vs-Female |
4.327400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.624400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.28629999995855E-06 |
| Normal-vs-Age(61-80Yrs) |
1.5800999999982E-05 |
| Normal-vs-Age(81-100Yrs) |
9.145700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.730400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.076000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.516800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.735600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.858200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.472400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.986600E-01 |
| Classical-VS-Follicular |
3.552400E-04 |
| Classical-VS-Other |
3.429000E-01 |
| Classical-VS-Normal |
1.215200E-03 |
| Tall-VS-Follicular |
1.385590E-02 |
| Tall-VS-Other |
2.858800E-01 |
| Tall-VS-Normal |
6.519800E-02 |
| Follicular-VS-Other |
8.063600E-01 |
| Follicular-VS-Normal |
1.2080000000303E-07 |
| Other-VS-Normal |
2.863600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.04939999812493E-08 |
| Normal-vs-N1 |
2.828600E-04 |
| N0-vs-N1 |
6.714000E-01 |
|
|
